cBioPortal revealed high mutation rates in BCL2, Myc, TP53, HDAC1, HDAC2, HDAC3, HDAC10, and BTK in the DLBCL samples (Fig. 1B). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.